Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Price:
14.18
CNY
1.94%
Market Closed
Market Cap:
¥15.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
|
CN |
|
Aksa Akrilik Kimya Sanayii AS
IST:AKSA.E
|
TR |
|
InspireMD Inc
NASDAQ:NSPR
|
IL |
|
N
|
NanoBrick Co Ltd
KOSDAQ:286750
|
KR |
|
Cr Credit Agricole Mutuel Loire Hte Loir
PAR:CRLO
|
FR |
|
D
|
Douglas Elliman Inc
NYSE:DOUG
|
US |
|
Petrolia Energy Corp
OTC:BBLS
|
US |
|
K
|
Konica Minolta Inc
OTC:KNCAY
|
JP |
|
Wisdom Wealth Resources Investment Holding Group Ltd
HKEX:7
|
HK |
|
F D C Ltd
NSE:FDC
|
IN |
|
M
|
Meitav Trade Investments Ltd
TASE:MTRD
|
IL |
|
G
|
Geely Automobile Holdings Ltd
F:GRUA
|
HK |
Multiples-Based Value
The Multiples-Based Value of one
Shenzhen Kangtai Biological Products Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 14.18 CNY,
Shenzhen Kangtai Biological Products Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Shenzhen Kangtai Biological Products Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Shenzhen Kangtai Biological Products Co Ltd Competitors
Shenzhen Kangtai Biological Products Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
|
15.8B CNY | 5.9 | -157.9 | -140.4 | -140.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
365B USD | 6 | 87.2 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.6B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.5B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD | 9.3 | 28.3 | 21.2 | 22.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.5 | 13 | 14.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.9B EUR | 11.8 | 37.9 | 40.9 | 41.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.1B AUD | 2.9 | 32.3 | 10.9 | 13.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
